Institute for Interdisciplinary Medicine

Recent papers from Institute for Interdisciplinary Medicine

1. Metabolic Dysfunction‐Associated Steatotic Disease and Genetic Risk in Germany—An Observational Real‐World Cohort StudyUnited European Gastroenterology Journal · 2026
2. Healthcare Utilization and Direct Medical Costs of Hepatocellular Carcinoma Treatment — A German Claims Data Study of 2778 PatientsPharmacoEconomics - Open · 2026
3. Decompression of portal hypertension by transjugular intrahepatic portosystemic shunt reverses markers of gut barrier dysfunction and cirrhosis-associated immune dysfunctionGut · 2026
4. EAST MEETS WEST—Medicated Driven Weight Loss Face (“Ozempic Face”): Unveiling the Profound Influence of Prescription Medications on Injectable Aesthetic Trends and Energy Based Device2026
5. Resolved HBV Infection Is Not Associated With Liver-Related Outcomes in Survival Analysis of Caucasians After HCV Cure.2026
6. Health-Related Quality of Life in Previous Versus Current Opiate Users Receiving HCV Therapy: Registry-Based EvidenceBrain Sciences · 2026
7. A Prospective Incidence Study on Sexually Transmitted Infections and HIV in Men Who Have Sex with Men with or without Use of Pre-Exposure-ProphylaxisOpen Forum Infectious Diseases · 2026
8. What can claims data tell us about risk factors and survival of patients with hepatocellular carcinoma? Insights from a German population-based studyFrontiers in Oncology · 2025
9. Increased Avoidance Learning in Chronic Opioid UsersJAMA Psychiatry · 2025
10. Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based studyTherapeutic Advances in Medical Oncology · 2025
11. Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis DLiver International · 2025
12. Physiological substantiation of the effect of mechanical impact on internal organs (literature review)Russian Osteopathic Journal · 2025
13. Overweight, but not alcohol is associated with increased risk for advanced liver disease in patients with chronic hepatitis C infection – results from the German hepatitis C-registry (Dhc-Zeitschrift für Gastroenterologie · 2025
14. Evaluating resmetirom eligibility among patients with metabolic dysfunction-associated steatohepatitis (MASH): insights from the German steatotic liver disease (SLD)-registryZeitschrift für Gastroenterologie · 2025
15. Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure – Data from the German Hepatitis C-Registry (DHC-R)Zeitschrift für Gastroenterologie · 2025
16. Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical OutcomeLiver International · 2024
17. Vascular protection in outpatient angiology: focus on regulatory peptidesRussian Journal of Cardiology and Cardiovascular Surgery · 2024
18. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJHEP Reports · 2024
19. NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational studyNeurology neuropsychiatry Psychosomatics · 2023
20. Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)Zeitschrift für Gastroenterologie · 2023